Brief Introduction of Jiangsu Haosen Pharmaceutical Group Subsidiary

Haosen Pharmaceutical Research Institute was established in 2002, with a total construction area of 30,000 square meters, integrating the functions of process research, preparation development, pharmacological analysis and clinical examination and approval. It is a nationally recognized enterprise technology center and an approved "postdoctoral research center", and is also the undertaker of some projects of the National 863 Program. In 2009, it successfully passed the certification of Jiangsu Key Biomedical Laboratory. Over the years, R&D Center has established extensive cooperative relations with well-known pharmaceutical research institutions at home and abroad, and its independent innovation capability ranks among the top five in the same industry in China. After eight years of scientific planning and development, Hausen Institute of Medicine has initially established a well-functioning organizational structure consisting of chemical research institute, biological research institute and pharmaceutical research institute, as well as functional departments such as quality department, new drug project department, new drug management department, process research department, pilot development department and patent affairs department. At the same time, through recruitment, introduction and internal training, a team of more than 350 people with appropriate professional collocation and matching academic level has been gradually established. Thanks to the joint efforts of scientific researchers in the whole hospital, many products and platform projects have been approved by the "National Major New Drug Creation Project" and the National Biomedical High-tech Industrialization Project, and many products have been recognized as "National Key New Products". The product research and development mode has changed from imitation to imitation innovation and independent innovation. 5 new drugs 1. 1 in preclinical research; 1. 1 9 new drugs with independent intellectual property rights have entered clinical research in each country; The innovative drug 1 is 1, which is in the production stage. These innovative drugs have shown good effectiveness and safety, and are expected to be put on the market from 20 12. In addition, Hausen Medical Research Institute also applied for 102 patents at home and abroad, including more than 40 compound patents and 24 PCT patents.

Hausen Pharmaceutical Research Institute has always adhered to the company's concept of "leapfrog development and self-transcendence", adhered to scientific planning and standardized management, and actively created a departmental culture of "innovative learning, harmonious respect and enterprising competition". With the goal of building a first-class team, creating first-class achievements and showing first-class elegance, it will surely lead the tide of new drug research and development in China, create more brilliant achievements, and also promote the by going up one flight of stairs of Haosen Pharmaceutical.

Brief Introduction of Shanghai Jiesen Pharmaceutical Chemistry Technology Co., Ltd.

Shanghai Jason Pharmaceutical Chemistry Technology Co., Ltd. was established in August, 20 1 1. It is a wholly-owned subsidiary of Haosen Pharmaceutical Group, located in Zhangjiang High-tech Park, Shanghai, and is mainly engaged in the development and research of chemical raw materials. The company has international advanced experimental instruments and nearly 100 world-class scientific and technological elites, which is the front window for the group to undertake the latest international pharmaceutical technology and attract high-tech talents. Lianyungang Hengyun Pharmaceutical Technology Co., Ltd. is one of the core enterprises of Haosen Pharmaceutical Group. Located in Lingang Industrial Zone, Guanyun County, Lianyungang City, with a total area of 400 mu, the first phase of the project is 200 mu. It mainly produces more than 65,438+00 kinds of pharmaceutical intermediates related to anti-tumor, diabetes and psychosis.